Insulet (PODD) EPS (Weighted Average and Diluted) (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.09% |
| Dec 31, 2025 | 15.32% |
| Sep 30, 2025 | 287.50% |
| Jun 30, 2025 | -36.00% |
| Mar 31, 2025 | -63.77% |
| Dec 31, 2024 | 27.78% |
| Sep 30, 2024 | -58.30% |
| Jun 30, 2024 | 254.79% |
| Mar 31, 2024 | -50.34% |
| Dec 31, 2023 | 98.65% |
| Sep 30, 2023 | 89.74% |
| Jun 30, 2023 | 14.71% |
| Mar 31, 2023 | 36.00% |
| Dec 31, 2022 | 412.50% |
| Sep 30, 2022 | 84.00% |
| Jun 30, 2022 | -225.00% |
| Mar 31, 2022 | -4.76% |
| Dec 31, 2021 | 133.33% |
| Sep 30, 2021 | 148.65% |
| Dec 31, 2020 | -252.94% |
| Sep 30, 2020 | -22.73% |
| Jun 30, 2020 | 833.33% |
| Mar 31, 2020 | -137.50% |
| Dec 31, 2019 | 700.00% |
| Sep 30, 2019 | -50.00% |
| Jun 30, 2019 | -71.43% |
| Mar 31, 2019 | -56.25% |
| Dec 31, 2018 | 433.33% |
| Sep 30, 2018 | 200.00% |
| Jun 30, 2018 | 72.73% |
| Mar 31, 2018 | 8.33% |
| Dec 31, 2017 | -200.00% |